SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-001024
Filing Date
2022-01-04
Accepted
2022-01-04 07:00:31
Documents
12
Period of Report
2022-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d245127d8k.htm   iXBRL 8-K 24254
  Complete submission text file 0001193125-22-001024.txt   149682

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rgen-20220103.xsd EX-101.SCH 2902
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20220103_lab.xml EX-101.LAB 18906
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20220103_pre.xml EX-101.PRE 11869
6 EXTRACTED XBRL INSTANCE DOCUMENT d245127d8k_htm.xml XML 3513
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 22504034
SIC: 2836 Biological Products, (No Diagnostic Substances)